Release of glutaraldehyde from an albumin-glutaraldehyde tissue adhesive causes significant in vitro and in vivo toxicity.

BACKGROUND A two-component sealant composed of bovine serum albumin and glutaraldehyde (BioGlue) is used to treat aortic dissections. Although glutaraldehyde guarantees strong adherence to tissues and synthetic materials, its toxic potential should be considered. The aim of this study was to determine the amount of glutaraldehyde released from BioGlue, its cytotoxic effects on cultured cells, and the local reaction of lung, liver, and aortic tissues to BioGlue. METHODS BioGlue was prepared according to the product insert, allowed to polymerize, and then overlaid with saline solution. The supernatant was analyzed for its content of glutaraldehyde. The cytotoxic effect of BioGlue was evaluated by adding the supernatants to either cultured human embryo fibroblasts (MRC5) or mouse myoblasts (C2C12). In vivo toxicity was assessed on three different tissues by applying BioGlue onto a partial lung resection, a liver abrasion, or an intact abdominal aorta in rabbits. Tissue samples were histologically evaluated 2 and 7 days after application. RESULTS Saline supernatants from polymerized BioGlue contained 100 to 200 mug/mL glutaraldehyde and were cytotoxic to both cell lines tested. Application of BioGlue to lung and liver tissue evoked serious adverse effects consisting of high-grade inflammation, edema, and toxic necrosis. Intact aortic tissue showed only low-grade or medium-grade inflammation. CONCLUSIONS Polymerized BioGlue releases amounts of glutaraldehyde that are capable of inducing cytotoxic effects both in vitro and in vivo. Use of BioGlue should be restricted to the aortic dissection procedure, as other tissues are sensitive to the amounts of glutaraldehyde released from the glue.

[1]  C. Pickering,et al.  Survey of symptoms, respiratory function, and immunology and their relation to glutaraldehyde and other occupational exposures among endoscopy nursing staff , 2000, Occupational and environmental medicine.

[2]  S. Gundry,et al.  Sutureless coronary artery bypass with biologic glued anastomoses: preliminary in vivo and in vitro results. , 2000, The Journal of thoracic and cardiovascular surgery.

[3]  S. Lenz,et al.  BioGlue surgical adhesive for thoracic aortic repair during coagulopathy: efficacy and histopathology. , 2001, The Annals of thoracic surgery.

[4]  J. Coselli,et al.  BioGlue surgical adhesive impairs aortic growth and causes anastomotic strictures. , 2002, The Annals of thoracic surgery.

[5]  Inflammatory response after BioGlue application. , 2002, The Annals of thoracic surgery.

[6]  J. Boratýnski,et al.  Colorimetric micromethods for glutaraldehyde determination by means of phenol and sulfuric acid or phenol and perchloric acid. , 1990, Analytical Biochemistry.

[7]  A. Kaye,et al.  Reconstruction of the sellar floor using Bioglue following transsphenoidal procedures , 2003, Journal of Clinical Neuroscience.

[8]  S. Downing.  What are the risks of using biologic glues? , 2003, The Annals of thoracic surgery.

[9]  J. Coselli,et al.  Thoracic Aortic Anastomoses , 2000 .

[10]  T. Nishimura,et al.  Some human B and T cell epitopes of bovine serum albumin, the major beef allergen. , 2002, Biochemical and biophysical research communications.

[11]  D. Latter,et al.  Use of "BioGlue" in aortic surgical repair. , 2001, The Annals of thoracic surgery.

[12]  T. Kazui,et al.  Role of biologic glue repair of proximal aortic dissection in the development of early and midterm redissection of the aortic root. , 2001, The Annals of thoracic surgery.

[13]  Yao Lu,et al.  Experimental use of an albumin-glutaraldehyde tissue adhesive for sealing pulmonary parenchyma and bronchial anastomoses. , 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.